相关实验视频
Updated: May 29, 2025

06:20
Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
Published on: October 4, 2022
2.6K
FOXM1-驱动的CKS1B上调促进胰腺癌的进展和治疗阻力
Liuxi Zhang1,2, Fang Wei1,2, Qihui Sun2
1Guangzhou First People's Hospital and The Second Affiliated Hospital, South China University of Technology School of Medicine, #1 Panfu Road, Guangzhou, Guangdong 510180, P.R. China.
International journal of biological sciences
|February 3, 2025
概括
CKS1B促进胰腺癌的生长和耐化疗. 针对FOXM1-CKS1B途径为胰腺管腺癌 (PDAC) 患者提供了一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 胰腺管道腺癌 (PDAC) 是一种致命的癌症,治疗结果不佳.
- 了解化学抵抗机制和确定新的治疗点对于PDAC至关重要.
- CKS1B在PDAC进展,干性和化学抵抗中的作用需要研究.
研究的目的:
- 研究CKS1B在胰腺管道腺癌 (PDAC) 中的作用.
- 探索PDAC中CKS1B上调的基础机制.
- 评估针对PDAC中的FOXM1-CKS1B轴的治疗潜力.
主要方法:
- 对PDAC组织和细胞系中CKS1B表达的分析.
- 在体外和体内研究评估CKS1B对PDAC细胞行为和化学敏感性的影响.
- 分子生物学技术用于探索FOXM1-CKS1B调节轴.
主要成果:
- 在PDAC中,CKS1B是上调调节的,并且与低生存率有关.
- CKS1B增强了PDAC细胞的增殖,迁移,干性和化学抵抗.
- CKS1B通过FOXM1进行转录调节,形成FOXM1-CKS1B信号轴.
结论:
- CKS1B是PDAC进展,干性和化学抵抗的关键驱动因素.
- FOXM1-CKS1B轴是一个新的信号通路,涉及PDAC.
- 针对FOXM1-CKS1B轴为PDAC提供了一个有前途的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K

